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Objective: The results of urinalysis, radiographic studies, urinary cytology examinations, and ureter-
orenoscopy (URS) biopsies, as well as the results of histopathology can be used to establish a diagnosis of
upper urinary tract urothelial carcinoma (UTUC).
Materials and Methods: We enrolled 99 patients who underwent radical nephroureterectomy (RNU)
during the period 2003e2007. A total of 65 random urine and 83 URS washing cytology examinations, 48
intravenous urography (IVU), 59 retrograde pyelography (RP), and 81 URS biopsy results were available
prior to RNU and were compared with the pathological grades and stages of these surgical specimens.
Results: Ninety-three UTUCs were found among the 99 RNU specimens. Initial presentations and uri-
nalysis results could not predict tumor stages. The patient with preoperative pyuria was signiﬁcantly
associated with high-grade UTUC (75.0% vs 52.6%, p ¼ 0.031). Random urine and URS washing cytology
results could not predict tumor grades or stages. The sensitivity of 3-day random urine cytology was
signiﬁcantly better than 2-day and 1-day examinations (p ¼ 0.002 and p ¼ 0.019, respectively). The
abnormal ﬁndings in IVU and RP accounted for 89.4% and 100%, respectively. Non-enhancement of
images was signiﬁcantly associated with high tumor grading (p ¼ 0.01). URS biopsy (n ¼ 72) was positive
for malignancy in 52 patients (69.3%). Biopsy grade had a signiﬁcant correlation with surgical tumor
grade (k ¼ 0.649) and high-grade biopsy results were signiﬁcantly associated with invasive tumor stage
(pT2eT4) (p ¼ 0.004).
Conclusion: Combining random urine cytology for 3 nonconsecutive days, upper urinary tract images,
and URS biopsies provided an accurate diagnosis of UTUC. This study found that preoperative pyuria in
urinalysis, non-enhancement in IVP or RP, and high-grade tumor in URS biopsy could predict high-grade
tumor in RNU specimens.
Copyright © 2015, Taiwan Urological Association. Published by Elsevier Taiwan LLC.
Open access under CC BY-NC-ND license.1. Introduction imaging, endoscopic inspection, and biopsy for histopathologicalThe incidence of upper urinary tract urothelial carcinoma
(UTUC) is high in Taiwan.1 Worldwide, UTUC, including carcinomas
of the renal pelvis and ureter, only accounts for 4e5% of all uro-
thelial cancer.2,3 However, in Taiwan, the ratio of renal pelvic uro-
thelial carcinoma (UC) to ureteral UC, and to bladder UC is 1.2:1:6.7,
which means UTUC is close to 25%.4 Previous studies showed that
31.2e34.1% of UTUC patients developed metachronous bladder UC
after radical nephroureterectomy (RNU) and bladder cuff resection,
the gold standard for treatment of UTUC.5,6
A diagnosis of upper urinary tract tumor is based on results of
urinalysis, urine cytology examination, upper urinary tractNational Taiwan University
d, Taipei 10016, Taiwan.
).
ciation. Published by Elsevier Taiwanalysis.7,8
We retrospectively reviewed patients receiving RNU and
bladder cuff resection because of suspected upper urinary tract
tumor after the ureterorenoscopy (URS) examinations, and inves-
tigated the sensitivities of urinalysis, random urine cytology, upper
urinary tract washing cytology, intravenous urography (IVU),
retrograde pyelography (RP), URS inspection, and biopsy in the
detection of UTUC in Taiwan. We also correlated these diagnostic
tools with the pathological staging and grading of UTUC to deter-
mine the effectiveness of these examinations.
2. Methods
From 2003 to 2007, 99 patients received RNU and bladder cuff
resection after URS examination in our institution. None of the
patients had a history of bladder or upper urinary tract UC. All ofan LLC. Open access under CC BY-NC-ND license.
Table 1
Initial presentations and urinalysis in upper urinary tract urothelial carcinoma
patients.
Results n (%)
Initial presentation
(n ¼ 93)
Gross hematuria 71 (76.3)
Flank pain or soreness 22 (23.7)
Abdominal discomfort 5 (5.3)
Abnormal ﬁndings in health examinationa 11 (11.5)
Body weight loss 3 (3.2)
Recurrent UTI 2 (2.2)
Urinalysis (n ¼ 93) Microscopic hematuria 63 (67.7)
Pyuria 36 (38.7)
Proteinuria 32 (34.4)
UTI ¼ urinary tract infection.
a Abnormal ﬁndings in health examination included microscopic hematuria,
hydronephrosis, renal mass, elevated creatinine, and anemia.
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scopic analysis prior to URS.
Microscopic hematuria was deﬁned as red blood cell counts >5
under high-power ﬁeld and pyuria was deﬁned as white blood cell
>5 under high-power ﬁeld. Proteinuria was deﬁned as urine con-
centration of protein of 30 mg/dL.
Other surveillance techniques included random urine cytology,
IVU, RP, computed tomography (CT), magnetic resonance image
(MRI), URS washing cytology, and URS biopsy. Positive ﬁndings of
random urine cytology and washing cytology included at least one
specimen with suspicious malignant cells or atypical cells. The
abnormal ﬁndings of the image studies included obstructive
uropathy, urinary tract ﬁlling defect, and visible tumors in the
radiographic examinations.
The combination of these surveillance tools depended on the
patients' conditions and the physicians' choices. Of the 99 patients,
99 urinalysis results, 65 random urine cytology results, 48 IVU re-
sults, 59 RP results, 81 CT results, 17 MRI results, 99 URS exami-
nations, 83 URS washing cytology results, and 81 biopsy results
were available.
The c2 test was used to analyze associations between diagnostic
tools and pathological parameters. The interobserver agreement
between URS and RUN pathological results was evaluated using the
Cohen's k method. A p value <0.05 was considered statistically
signiﬁcant.3. Results
Of the 99 patients who received RNU and bladder cuff resection
due to diagnosis or suspicion of UTUCs, six had RNU specimens
without UC. Two of the patients had URS biopsy specimens that
revealed superﬁcial low-grade UC without lamina propria invasion.
Two of the patients had renal cell carcinomas. The other two pa-
tients had biopsy specimens that showedmesenchymal polyps and
papilloma, respectively.
Ninety-three patients had pathologically proven UC in the
upper urinary tract, including 49 women (52.7%) and 44 men
(47.3%). The median age of all UTUC patients was 69 years
(interquartile range, 58e74 years). UC was found on the left side
in 47 patients (50.5%), on the right side in 44 patients (47.3%),
and on both sides in two patients (2.2%). UC was located only at
the renal pelvis in 40 patients (43.0%), only at the ureter in 31
patients (33.3%), and at both renal pelvis and ureter in 22 pa-
tients (23.7%).
A total of 93 urinalysis results, 62 random urine cytology results,
47 IVU results, 54 RP results, 78 CT results, 16 MRI results, 93 URS
examinations, 77 URS washing cytology results, and 75 biopsy re-
sults were available in the cohort of 93 UTUC patients.Table 2
Urine cytological and pathological results.
Cytology
results, n (%)
High-grade UC (%) Invasive tumor (%)
Random urine
cytology (n ¼ 62)
Negative 26 (41.9) 50.0 p ¼ 0.121 42.3 p ¼ 0.96
Positive 36 (58.1) 69.4 41.7
URS washing
cytology (n ¼ 77)
Negative 32 (41.6) 46.9 p ¼ 0.053 34.4 p ¼ 0.1
Positive 45 (58.4) 68.9 53.3
UC ¼ urothelial carcinoma; URS ¼ ureterorenoscopy.3.1. Initial presentations and urinalysis
Initial presentations are listed in Table 1. The most common
symptom was gross hematuria in 71 patients (76.3%). Eleven pa-
tients (11.5%) visited urology clinics because abnormal ﬁndings had
been disclosed at hospitals elsewhere, including microscopic he-
maturia, renal function impairment, anemia or hydronephrosis,
and ultrasonographic evidence of a renal mass.
Urinalysis was obtained prior to URS studies and showed
microscopic hematuria in 67.7% (n ¼ 63), pyuria in 38.7%
(n ¼ 36), and proteinuria in 34.4% (n ¼ 32) of patients (Table 1).
Initial presentations and urinalysis results could not predict tu-
mor staging. Interestingly, patients with pyuria had a signiﬁ-
cantly higher percentage of high-grade UC (75.0% vs 52.6%,
p ¼ 0.031).3.2. Cytology
Random urine cytology and URS washing cytology results were
available for 62 patients and 77 patients, respectively. The sensi-
tivity of random urine cytology and URS washing cytology was
58.1% and 58.4%, respectively (Table 2). Thirty-nine patients sub-
mitted random 3-day urine cytology specimens, nine patients
submitted 2-day results, and 14 patients submitted 1-day results.
The sensitivity of 3-, 2-, and 1-day collection of random urine
cytology results was 74.4%, 33.3%, and 28.6%, respectively. Three-
day random urine cytology was signiﬁcantly better than 2- and 1-
day urine cytology (p ¼ 0.002 and p ¼ 0.019, respectively); how-
ever, there was no difference between 2- and 1-day urine cytology
sensitivity (p ¼ 0.809).
The contributions of high pathological grade and invasive tumor
stage stratiﬁed by results of random urine cytology and upper
urinary tract washing urine cytology are listed in Table 2. There
were no associations between cytology collecting methods or
predictions of tumor grading and staging.
3.3. Upper urinary tract imaging
Of the 47 patients with IVU prior to URS examinations,19.1% had
hydronephrosis, 19.1% had non-enhancement of upper urinary
tract, 51.1% had urinary tract ﬁlling defects, and 10.6% had no def-
inite abnormal ﬁndings. A total of 54 patients received RP following
URS studies. The procedures showed hydronephrosis in 7.4%, non-
enhancement of upper urinary tract in 3.7%, urinary tract ﬁlling
defects in 88.9%, and no deﬁnite abnormal ﬁnding in any of the
patients.
The contributions of pathological results in IVU and RP charac-
teristics are demonstrated in Table 3. Non-enhancement in the
upper urinary tract group had signiﬁcant superiority over the no
deﬁnite abnormal ﬁnding group in predicting high tumor grading
(p ¼ 0.01). The results of CT were available in 78 patients and
showed simply hydronephrosis, suspected upper urinary tract tu-
mors, and no deﬁnite abnormal ﬁndings in seven (9.0%) patients, 70
Table 3
Upper urinary tract images and pathological results.
Characteristics n (%) High-grade
UC (%)
Invasive
tumora (%)
IVU (n ¼ 47) No deﬁnite abnormal ﬁnding 5 (10.6) 20.0 20.0
Hydronephrosis 9 (19.1) 55.6 44.4
Non-enhancement 9 (19.1) 88.9 66.7
Filling defects 24 (51.1) 58.3 41.7
RP (n ¼ 54) No deﬁnite abnormal ﬁnding 0 (0) 0 0
Hydronephrosis 4 (7.4) 50 50
Non-enhancement 2 (3.7) 100 50
Filling defects 48 (88.9) 60.4 47.9
IVU ¼ intravenous urography; RP ¼ retrograde pyelography; UC ¼ urothelial
carcinoma.
a Invasive tumor was deﬁned as pathological tumor stage T2eT4.
Table 5
Correlation between pathologic results of URS biopsies and RNU specimens.
URS biopsy, n ¼ 52
Low-grade UC
n ¼ 24 (46.2%)
High-grade UC
n ¼ 28 (53.8%)
RNU
specimen
Tumor grade,
n (%)
Low 18 (75.0) 3 (10.7) p < 0.001
High 6 (25.0) 25 (89.3)
Tumor stage,
n (%)
Tcis, Ta, T1 19 (79.2) 11 (39.3) p ¼ 0.004
T2eT4 5 (20.8) 17 (60.7)
RNU ¼ radical nephroureterectomy; UC ¼ urothelial carcinoma;
URS ¼ ureterorenoscopy.
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tients underwent MRI and all of them showed suspected upper
urinary tract tumors. The upper urinary tract imaging provided
limited information in predicting tumor grading and the depth of
tumor invasion.
3.4. URS inspection and biopsy
URS inspection of suspected upper urinary tract tumor was
documented in 82 (88.2%) patients and URS biopsies were per-
formed in 75 (81.6%) patients. The histopathological results of URS
biopsies are listed in Table 4. Fifty-two biopsy specimens were
found to be UCs, including 24 (46.2%) of low grade and 28 (53.8%) of
high grade. The UC detection rate of URS biopsy was 69.3%. Of the
52 patients with UC in URS biopsy specimens, there was a signiﬁ-
cant correlation between URS biopsy grade and ﬁnal tumor grade
(k ¼ 0.649, p < 0.001).
After examination of the RNU specimens, pathological stage
Tcis, Ta, T1, T2, and T3 accounted for 2.2% (n ¼ 2), 25.8% (n ¼ 24),
25.8% (n ¼ 24), 14% (n ¼ 13), and 32.2% (n ¼ 30), respectively
(Table 5). Of the patients with low- and high-grade UC in URS bi-
opsy, the percentages of invasive UC were 20.8% and 60.7%,
respectively. The high-grade tumor in URS biopsy was signiﬁcantly
associatedwith invasive tumor stage in RNU specimens (p¼ 0.004).
Lamina propria was noted histologically in only three URS biopsy
specimens, including two Ta stage and at least one T1 stage lesions.
Seventy-two (96%) URS biopsy specimens showed only superﬁcial
layers in urothelial tumors and seemed to be not available to
evaluate the accurate depth of malignant invasion.
4. Discussion
The standard treatment for UTUC is RNU with bladder cuff
resection. Recently, some studies proposed the idea that conser-
vative treatment with endoscopic laser ablation is safe and effectiveTable 4
Histopathological results of ureterorenoscopy biopsies.
Results n (%)
Low-grade UC 24 (32.0)
High-grade UC 28 (37.3)
Papillary urothelial neoplasm with low malignant potential 5 (6.7)
Chronic inﬂammation 5 (6.7)
Atypical urothelial cells 4 (5.3)
Dysplasia 3 (4.0)
Inadequate specimens for diagnosis 3 (4.0)
Hyalinization 1 (1.3)
Reactive changes 1 (1.3)
Muscular hypertrophy 1 (1.3)
UC ¼ urothelial carcinoma.in selected cases with low-grade, low-stage disease.9 Thus, accurate
preoperative grading and staging with the available diagnostic in-
formation is of great importance. Li et al6 reported that tumor stage
was a signiﬁcant predictor of cancer-speciﬁc survival in Taiwanese
UTUC patients.
The detection of UTUC cannot be achieved by a single diagnostic
tool. At initial assessment, patients often present with microscopic
hematuria. Standard assessment includes cystoscopy, upper urinary
tract imaging, and urine cytology, followed by RP, endoscopy, and
biopsy.10 The regimen with cystoscopy, urine cytology, upper tract
imaging, and RP can establish the diagnosis in 50e60% of patients.
The accuracy increases to 80e90% with URS.11 In our study, the
sensitivity of urine cytology, washing cytology, IVU, RP, CT, MRI, URS
inspection, and URS biopsy was 58.1%, 58.4%, 89.4%, 100%, 98.7%,
100%, 88.2%, and 69.3%, respectively. Urine cytology, IVU, and RP
achieved the diagnosis of suspicious UTUC in 96.7% of patients. These
diagnostic tools compensate for the weakness of other methods.
In our study, initial presenting symptoms, microscopic hema-
turia, and proteinuria had no correlation with tumor staging and
grading. Recently, studies have noted that patients with chronic
kidney disease had a worse prognosis and higher proportion of
high-grade tumor with UTUC than those with normal renal func-
tion.4 As for proteinuria, an indicator of chronic kidney disease, we
did not notice any signiﬁcant correlation between proteinuria and
tumor grade/stage. However, patients with pyuria had a signiﬁ-
cantly higher percentage of high-grade tumor than those without
pyuria.
The European Association of Urology guidelines on the diagnosis
of UTUC suggest that IVU is the ﬁrst choice for investigating he-
maturia, that RP might be useful in cases with equivocal IVU ﬁnd-
ings, and that CT might be difﬁcult to diagnose accurately small-
volume tumors in the renal pelvis or ureter.12 Cowan et al13 docu-
mented that the sensitivity of CT and RP in the diagnosis of UTUC
was 97% and 93%, respectively, and CT should be used before RP as a
noninvasive comprehensive tool. The sensitivity of these upper
urinary tract images was similar in our study. Previous studies have
shown that poor visualization of the renal collecting system in IVU
is an indicator of invasive UTUC.14 We noted that the non-
enhancement presentation in IVU had a special predictive value
for a high-grade tumor. Although the upper urinary tract imaging
was not effective in predicting tumor grading and the depth of
tumor invasion in our results, CT/MRI scans still play an important
and essential role for cancer staging to detect tumor invasion to
adjacent organs/tissue, lymphadenopathy, or distal metastases.
Previous studies have stated that the sensitivity of urine
cytology is poor in low-grade tumors and better in high-grade tu-
mors.15 We noted that the sensitivity of random urine cytology in
high- and low-grade tumors was 65.8% and 45.8%, respectively,
although without any signiﬁcant difference. After identifying the
patients with three sets of cytology results, the sensitivity in high-
and low-grade tumors was elevated to 76% and 71.4%, respectively,
still without a signiﬁcant difference. Skolarikos et al16 stated that
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improved the predictive power of the ﬁnal pathological grade and
stage. Although we noted that the percentage of high-grade tumor
was higher in patients with positive random urine cytology or
positive washing cytology, and the percentage of invasive tumor
was higher in those with positive washing cytology, these ﬁndings
did not reach signiﬁcance, possibly due to the limited case
numbers. However, as for random voided urine cytology, three sets
of specimens yielded signiﬁcantly higher sensitivity than one or
two sets of specimens. The noninvasive collection of three sets of
random urine cytology in three nonconsecutive days had a sensi-
tivity of 74.4%, which was even better than ureteral/renal pelvic
washing cytology.
Huben et al2 noticed tumor grade (low/high) matched tumor
stage (superﬁcial/invasive) in 83% of UTUC, and both tumor stage and
gradewere predictive of prognosis.We found that tumor grade (low/
high) matched tumor stage (Ta, Tcis, T1/T2e4) in 69.8% with statis-
tical signiﬁcance, and URS biopsy grade also matched stage in 69.2%
with statistical signiﬁcance. However, the sensitivity of URS biopsy,
69.3%, was not satisfactory. Guarnizo proposed that a multi-biopsy
approach could improve diagnostic accuracy. With each lesion bio-
psied 2e6 times, the tissue diagnosis of UCwas achieved in 89%, and
the biopsy results matched the exact tumor grade in 78%.17
In conclusion, accurate diagnosis of UTUC should combine urine
cytology, upper urinary tract images, URS inspection, and biopsy.
Collecting random voided urine for three nonconsecutive days
could signiﬁcantly elevate the sensitivity. Pyuria in urinalysis, non-
enhancement in IVU or RP images, and high-grade URS biopsy
could predict high-grade tumor.Conﬂicts of interest
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